Biosensors International Group Ltd

Rue de Lausanne 29, Morges, 1110, Switzerland
Tel: + 41 21 804 80 00 | Fax: + 41 21 804 80 02

About Biosensors International
The Biosensors International group of companies develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. Our aim is to improve patients’ lives through pioneering medical technology that pushes forward the boundaries of innovation.

Products & Technology
The Interventional Cardiology and Critical Care Products divisions both have track records of innovation in the development of next-generation medical technologies that make a difference in patients’ lives. A worldwide sales and marketing team and a network of distributors deliver our products to where they can help most.

  • Interventional Cardiology
    The Interventional Cardiology division is focused on the development, manufacture and commercialization of drug-eluting stents, bare metal stents and angioplasty catheters.

    Drug-Eluting Stents (DES)
    BioMatrix™ is Biosensors’ unique abluminal biodegradable polymer DES. Its abluminal coating is absorbed after 6 to 9 months (Data on file molecular weight <10kDa). It combines the proven safety of a DES with an abluminal biodegradable polymer, the proven efficacy of BA9™ and an advanced stent design.

    Not available for sale in the United States and certain other countries

    Bare Metal Stents
    The latest generation bare metal stent, Gazelle™ (commercialized under the name S-Stent™ in Japan), has been developed using the proprietary Quadrature Link™ design for enhanced flexibility. Available in a broad range of sizes, the proven stent platform provides the deliverability necessary for easy positioning.

    Not available for sale in the United States and certain other countries

    Balloon Dilatation Catheters
    Powerline™ offers excellent trackability and crossability for the treatment of complex lesions. The unique automated MultiPleat™ folding technology provides consistently low primary and secondary profiles to facilitate treatment of multi-vessel disease.

    Not available for sale in the United States and certain other countries.














Critical Care Products
The Critical Care Products division develops and manufactures vascular catheters, pressure monitoring kits, arterial blood sampling kits and blood pressure transducers for use in open heart surgery and critical care areas of the hospital.

The cited trademarks are the property of Biosensors International Group, Ltd





Suggest a topic for future coverage